Company Inovio Pharmaceuticals Inc Nyse
Equities
US45773H1023
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
DNA Medicines
100.0
%
| 10 | 100.0 % | 1 | 100.0 % | -91.89% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 10 | 100.0 % | 1 | 100.0 % | -91.89% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 25/19/25 |
Peter Kies
DFI | Director of Finance/CFO | 60 | 01/02/01 |
Chief Tech/Sci/R&D Officer | - | 01/07/01 | |
Jeffrey Skolnik
CTO | Chief Tech/Sci/R&D Officer | - | 12/16/12 |
Michael Sumner
CTO | Chief Tech/Sci/R&D Officer | 59 | 27/22/27 |
Laurent Humeau
CTO | Chief Tech/Sci/R&D Officer | 57 | 18/14/18 |
Thomas Hong
IRC | Investor Relations Contact | - | - |
Cheryl Elder
LAW | General Counsel | - | - |
Shawn D. Bridy
PRN | Corporate Officer/Principal | - | 24/18/24 |
Maggie Campbell
AUD | Comptroller/Controller/Auditor | - | 01/06/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Benito
CHM | Chairman | 79 | 01/03/01 |
Lota Zoth
BRD | Director/Board Member | 64 | 01/18/01 |
Jay Shepard
BRD | Director/Board Member | 65 | 15/20/15 |
Wendy Yarno
BRD | Director/Board Member | 69 | 06/17/06 |
David Weiner
FOU | Founder | 67 | 29/83/29 |
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 25/19/25 |
Roger Dansey
BRD | Director/Board Member | 68 | 13/21/13 |
Ann Miller
BRD | Director/Board Member | 66 | 25/19/25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,091 | 0 | 1,082 ( 99.18 %) | 98.51 % |
Stock B | 1 | 25,329,333 | 24,953,826 ( 98.52 %) | 0 |
Company contact information
Inovio Pharmaceuticals, Inc.
660 West Germantown Pike Suite 110
19462-1111, Plymouth Meeting
+267 440 4200
http://www.inovio.comSector
1st Jan change | Capi. | |
---|---|---|
+22.81% | 46.81B | |
+46.68% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |
- Stock Market
- Equities
- INO Stock
- Stock
- Company Inovio Pharmaceuticals Inc